title: Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma.
authors.affiliation: Department of Laboratory Medicine, Konyang University Hospital, College of Medical Science, Konyang University, Seo-gu, Daejon, Korea.
authors.forename: Hyun-Jung
authors.initials: HJ
authors.lastname: Cho
authors.forename: Hyeon-Seok
authors.initials: HS
authors.lastname: Eom
authors.forename: Hyun-Ju
authors.initials: HJ
authors.lastname: Kim
authors.forename: In-Suk
authors.initials: IS
authors.lastname: Kim
authors.forename: Gyeong Won
authors.initials: GW
authors.lastname: Lee
authors.forename: Sun-Young
authors.initials: SY
authors.lastname: Kong
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D044466:Asian People / Q000235:genetics; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D017353:Gene Deletion; D005838:Genotype; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D007723:Korea; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D011241:Prednisone / Q000009:adverse effects; D011379:Prognosis; D012306:Risk; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000009:adverse effects
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D003520:Cyclophosphamide; D004317:Doxorubicin; D051549:Glutathione S-Transferase pi; D005982:Glutathione Transferase; D011241:Prednisone; D000069283:Rituximab; D014750:Vincristine; C413545:glutathione S-transferase T1